We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Neurologix Commences its Phase II Clinical Trial of Gene Transfer Approach for Treatment of Parkinson's Disease

News   Jan 22, 2009

 
Neurologix Commences its Phase II Clinical Trial of Gene Transfer Approach for Treatment of Parkinson's Disease
 
 
 

RELATED ARTICLES

10-year Study Provides Breakthrough in Understanding Male Infertility

News

Hope has emerged for infertile men as scientists have understood the importance of a gene in regulating the production of fully-functioning sperm.

READ MORE

Temperature-stable Tuberculosis Vaccine Enters Clinical Testing

News

Vaccinations have begun in a Phase 1 human clinical trial testing a freeze-dried, temperature-stable formulation of an experimental tuberculosis vaccine candidate.

READ MORE

Genome Overlap in Human Mental Disorders and Canine Behavior

News

Researchers have identified two novel anxiety related genomic regions in German Shepherd dogs.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE